High frequency of several PIG-A mutations in patients with aplastic anemia and myelodysplastic syndrome

Leukemia

Volumn 20, Issue 4, 2006, Pages 627-634

  Okamoto, M ^a   Shichishima, T ^a,b   Noji, H ^a   Ikeda, K ^a   Nakamura, A ^a   Akutsu, K ^a   Maruyama, Y ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b Fukushima Research Institute of Environment and Medicine   (Japan)

Author keywords

Aplastic anemia (AA); Glycosylphosphatidylinositol (GPI) anchored membrane protein; Myelodysplastic syndrome (MDS); Paroxysmal nocturnal hemoglobinuria (PNH) clone(s); Phosphatidylinositol glycan class A (PIG A) gene

Indexed keywords

CD48 ANTIGEN; CD59 ANTIGEN; CYCLOSPORIN A; GENOMIC DNA; GLYCOSYLPHOSPHATIDYLINOSITOL; MEMBRANE PROTEIN; METENOLONE ACETATE; PHOSPHATIDYLINOSITOL GLYCAN A; PREDNISOLONE; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; APLASTIC ANEMIA; ARTICLE; BLOOD SAMPLING; CELL SELECTION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; FRAMESHIFT MUTATION; GENE DELETION; GENE FREQUENCY; GENE MUTATION; GENOME ANALYSIS; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; JAPAN; MALE; MISSENSE MUTATION; MONOCYTE; MYELODYSPLASTIC SYNDROME; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS; SEQUENCE ANALYSIS;

EID: 33646490301     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404135     Document Type: Article

References (34)

1. Takeda J, Miyata T, Kawagoe K, Iida Y, Endo Y, Fujita T et al. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 1993; 73: 703-711.
2. Miyata T, Takeda J, Iida Y, Yamada N, Inoue N, Takahashi M et al. The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis. Science 1993; 259: 1318-1320.
3. Shichishima T, Noji H. A new aspect of the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria. Hematology 2002; 7: 211-227.
4. Young NS. The problem of clonality in aplastic anemia: Dr Dameshek's riddle, restated. Blood 1992; 79: 1385-1392.
5. Schubert J, Vogt HG, Zielinska-Skowronek M, Freund M, Kaltwasser JP, Hoelzer D et al. Development of the glycosylphosphatidylinositol-anchoring defect characteristic for paroxysmal nocturnal hemoglobinuria in patients with aplastic anemia. Blood 1994; 83: 2323-2328.
6. Schrezenmeier H, Hertenstein B, Wagner B, Raghavachar A, Heimpel H. A pathogenetic link between aplastic anemia and paroxysmal nocturnal hemoglobinuria is suggested by a high frequency of aplastic anemia patients with a deficiency of phosphatidylinositol glycan anchored proteins. Exp Hematol 1995; 23: 81-87.
7. Tooze JA, Saso R, Marsh JCW, Papadopoulos A, Pulford K, Gordon-Smith EC. The novel monoclonal antibody By114 helps detect the early emergence of a paroxysmal nocturnal hemoglobinuria clone in aplastic anemia. Exp Hematol 1995; 23: 1484-1491.
8. Yamaguchi M, Nakao S, Takamatsu H, Chuhjo T, Shiobara S, Matsuda T. Quality of hematologic recovery in patients with aplastic anemia following cyclosporine therapy. Exp Hematol 1995; 23: 341-346.
9. Griscelli-Bennaceur A, Gluckman E, Scrobohaci ML, Jonveaux P, Vu T, Bazarbachi A et al. Aplastic anemia and paroxysmal nocturnal hemoglobinuria: Search for a pathogenetic link. Blood 1995; 85: 1354-1363.
10. De Lord C, Tooze JA, Saso R, March JCW, Gordon-Smith EC. Deficiency of glycosilphosphatidyl inositol-anchored proteins in patients with aplastic anaemia does not affect response to immunosuppressive therapy. Br J Haematol 1998; 101: 90-93.
11. Azenishi Y, Ueda E, Machii T, Nishimura J, Hirota T, Shibano M et al. CD59-deficient blood cells and PIG-A gene abnormalities in Japanese patients with aplastic anaemia. Br J Haematol 1999; 104: 523-529.
12. Dunn DE, Tanawattanacharoen P, Boccuni P, Nagakura S, Green SW, Kirby MR et al. Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes. Ann Intern Med 1999; 131: 401-408.
13. Piaggio G, Podestà M, Pitto A, Sessarego M, Figari O, Fugazza G et al. Coexistence of normal and clonal haemopoiesis in aplastic anaemia patients treated with immunosuppressive therapy. Br J Haematol 1999; 107: 505-511.
14. Wang H, Chuhjo T, Yamazaki H, Shiobara S, Teramura M, Mizoguchi H et al. Relative increase of granulocytes with a paroxysmal nocturnal haemoglobinuria phenotype in aplastic anaemia patients: The high prevalence at diagnosis. Eur J Haematol 2001; 66: 200-205.
15. Iwanaga M, Furukawa K, Amenomori T, Mori H, Nakamura H, Fuchigami K et al. Paroxysmal nocturnal haemoglobinuria clones in patients with myelodysplastic syndromes. Br J Haematol 1998; 102: 465-474.
16. Meletis J, Terpos E, Samarkos M, Meletis C, Konstantopoulos K, Komninaka V et al. Detection of CD55 and/or CD59 deficient red cell populations in patients with aplastic anaemia, myelodysplastic syndromes and myeloproliferative disorders. Haematologia 2001; 31: 7-16.
17. Wang H, Chuhjo T, Yasue S, Omine M, Nakao S. Clinical significance of a minor population of paroxysmal nocturnal hemoglobinuria-type cells in bone marrow failure syndrome. Blood 2002; 100: 3897-3902.
18. Kawaguchi K, Wada H, Mori A, Takemoto Y, Kakishita E, Kanamaru A. Detection of GPI-anchored protein-deficient cells in patients with aplastic anaemia and evidence for clonal expansion during the clinical course. Br J Haematol 1999; 105: 80-84.
19. Mortazavi Y, Merk B, McIntosh J, Marsh JCW, Schrezenmeier H, Rutherford TR. The spectrum of PIG-A gene mutations in aplastic anemia/paroxysmal nocturnal hemoglobinuria (AA/PNH): A high incidence of multiple mutations and evidence of a mutational hot spot. Blood 2003; 101: 2833-2841.
20. International Agranulocytosis and Aplastic Anemia Study. Incidence of aplastic anemia: The relevance of diagnostic criteria. Blood 1987; 70: 1718-1721.
21. Frickhofen N, Kaltwasser JP, Schrezenmeier H, Raghavachar A, Vogt HG, Herrmann F et al. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. N Engl J Med 1991; 324: 1297-1304.
22. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. The French-American-British (FAB) Cooperative Group. Proposals for the classification of the myelodysplastic syndromes. Br J Heamatol 1982; 51: 189-199.
23. Shichishima T, Terasawa T, Hashimoto C, Ohto H, Uchida T, Maruyama Y. Heterogenous expression of decay accelerating factor and CD59/membrane attack complex inhibition factor on paroxysmal nocturnal haemoglobinuria (PNH) erythrocytes. Br J Haematol 1991; 78: 545-550.
24. Hall SE, Rosse WF. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria. Blood 1996; 87: 5332-5340.
25. Lewis SM, Dacie JP. The aplastic anaemia-paroxysmal nocturnal haemoglobinuria syndrome. Br J Haematol 1967; 13: 236-251.
26. Sugita Y, Mazda T, Tomita M. Amino-terminal amino acid sequence and chemical and functional properties of a membrane attack complex-inhibitory factor from human erythrocyte membranes. J Biochem 1989; 106: 589-592.
27. Shichishima T, Terasawa T, Saitoh Y, Hashimoto C, Ohto H, Maruyama Y. Diagnosis of paroxysmal nocturnal haemoglobinuria by phenotypic analysis of erythrocytes using two-colour flow cytometry with monoclonal antibodies to DAF and CD59/MACIF. Br J Haematol 1993; 85: 378-386.
28. Noji H, Shichishima T, Saitoh Y, Kai T, Yamamoto T, Ogawa K et al. The distribution of PIG-A gene abnormalities in paroxysmal nocturnal hemoglobinuria granulocytes and cultured erythroblasts. Exp Hematol 2001; 29: 391-400.
29. Kai T, Shichishima T, Noji H, Yamamoto T, Okamoto M, Ikeda K et al. Phenotypes and phosphatidylinositol glycan-class A gene abnormalities during cell differentiation and maturation from precursor cells to mature granulocytes in patients with paroxysmal nocturnal hemoglobinuria. Blood 2002; 100: 3812-3818.
30. Iida Y, Takeda J, Miyata T, Inoue N, Nishimura J, Kitani T et al. Characterization of genomic PIG-A gene: A gene for glycosylphosphatidylinositolanchor biosynthesis and paroxysmal nocturnal hemoglobinuria. Blood 1994; 83: 3126-3131.
31. Araten DJ, Nafa K, Pakdeesuwan K, Luzzatto L. Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. Proc Natl Acad Sci USA 1999; 96: 5209-5214.
32. Hu R, Mukhina GL, Piantadosi S, Barber JP, Jones RJ, Brodsky RA. PIG-A mutations in normal hematopoiesis. Blood 2005; 105: 3848-3854.
33. Luzzatto L, Bessler M. The dual pathogenesis of paroxysmal nocturnal hemoglobinura. Curr Opin Hematol 1996; 3: 101-110.
34. Nishimura J, Hirota T, Kanakura Y, Machii T, Kageyama T, Doi S et al. Long-term support of hematopoiesis by a single stem cell clone in patients with paroxysmal nocturnal hemoglobinuria. Blood 2002; 99: 2748-2751.